Carrier-Free Nano-Proteolysis Targeting Chimeras Enable Selective Protein Degradation and Enhance Photoimmunometabolic Therapy against Lung Adenocarcinoma
ACS Nano · 2026
DOI: 10.1021/acsnano.5c21154 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Xuechun Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, C…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, the Large-scale Instrument and Equipment Open Sharing Foundation of Medical Science and Technology Innovation Center, Shandong First Medical University & Shand….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
- Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.
- Department of Biochemistry and Molecular Biology, School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong 250117, China.
ORCID-Profile: Guiqiang Zhang
Förderung
- Natural Science Foundation of Shandong Province
- the Large-scale Instrument and Equipment Open Sharing Foundation of Medical Science and Technology Innovation Center, Shandong First Medical University & Shand…
Zitieren
APA
Wang, X., Liu, L., Tian, J., Kong, Z., Lv, F., Yan, J., Li, S., Ma, Z., Guo, D., Wang, Y., Gu, C., & Zhang, G. (2026). Carrier-Free Nano-Proteolysis Targeting Chimeras Enable Selective Protein Degradation and Enhance Photoimmunometabolic Therapy against Lung Adenocarcinoma. ACS Nano. https://doi.org/10.1021/acsnano.5c21154
Vancouver
Wang X, Liu L, Tian J, Kong Z, Lv F, Yan J, et al. Carrier-Free Nano-Proteolysis Targeting Chimeras Enable Selective Protein Degradation and Enhance Photoimmunometabolic Therapy against Lung Adenocarcinoma. ACS Nano. 2026. doi:10.1021/acsnano.5c21154
BibTeX
@article{Wang2026,
author = {Wang, Xuechun and Liu, Liu and Tian, Jing and Kong, Zhe and Lv, Fei and Yan, Jie and Li, Songyan and Ma, Zilin and Guo, Dianhao and Wang, Yuelan and Gu, Changping and Zhang, Guiqiang},
title = {Carrier-Free Nano-Proteolysis Targeting Chimeras Enable Selective Protein Degradation and Enhance Photoimmunometabolic Therapy against Lung Adenocarcinoma},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.5c21154}
}
EUVIMED